Search Within

Radiology, Department of

Formats
  1. Journal Article (4769)
  2. Meeting Abstract (1951)
  3. Book Section (405)
  4. Review (397)
  5. Editorial (133)
  6. Conference Paper (98)
  7. Guidelines (73)
  8. Miscellaneous (30)
  9. Research Letter (29)
  10. Correspondence (25)
  11. Book Whole (22)
Groups
  1. Molecular Imaging and Therapy Service (3070)
  2. GSK Faculty (2909)
  3. Body Imaging Service (2559)
  4. Department of Medicine (2391)
  5. Sloan Kettering Institute Postdocs (1897)
  6. Sloan Kettering Institute Faculty (1862)

More Groups

People
  1. Steven Larson (959)
  2. Heiko Schoder (550)
  3. Jason Lewis (458)
  4. Stephen Solomon (426)
  5. Hedvig Hricak (421)
  6. Neeta Pandit-Taskar (344)

More People

Years
  1. 2025 (189)
  2. 2024 (440)
  3. 2023 (497)
  4. 2022 (491)
  5. 2021 (449)
  6. 2020 (470)

More Years

Publications
  1. Journal of Nuclear Medicine (695)
  2. Journal of Clinical Oncology (624)
  3. American Journal of Roentgenology (265)
  4. Radiology (249)
  5. Journal of Vascular and Interventional Radiology (190)
  6. International Journal of Radiation Oncology, Biology, Physics (162)

More Publications

Publishers
  1. Springer (923)
  2. Elsevier Inc. (782)
  3. Society of Nuclear Medicine (695)
  4. American Society of Clinical Oncology (663)
  5. Elsevier Science, Inc. (481)
  6. American Association for Cancer Research (357)

More Publishers

Results (7932)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC)
    Meeting Abstract

    Cercek, A.; Kemeny, N. E.; Boerner, T.; Tan, B. R.; Chou, J. F.; Gonen, M.; Boucher, T. M.; Hauser, H.; Do, R. K. G.; Lowery, M. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Peptide receptor radionuclide therapy (PRRT) transcriptomic signature in blood for prediction of (177)Lu-octreotate efficacy
    Meeting Abstract

    Bodei, L.; Kidd, M. S.; Singh, A.; van der Zwan, W. A.; Severi, S.; Drozdov, I.; Cwikla, J. B.; Baum, R. P.; Kwekkeboom, D. J.; Paganelli, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • MRI texture features and outcomes to immune checkpoint inhibitors in melanoma brain metastases
    Meeting Abstract

    Bhatia, A.; Birger, M.; Veeraraghavan, H.; Um, H.; McKenney, A. S.; Cugliari, M.; Caviasco, A.; Bialczak, A.; Malani, R.; Zhang, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Deleterious effect of baseline steroids on efficacy of PD-(L)1 blockade in patients with NSCLC
    Meeting Abstract

    Arbour, K. C.; Mezquita, L.; Long, N.; Rizvi, H.; Auclin, E.; Ni, A.; Bernal, G. M.; Chaft, J. E.; Ferrara, R.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial
    Meeting Abstract

    Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pilot study of gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban for advanced pancreatic adenocarcinoma: An interim analysis
    Meeting Abstract

    Yu, K. H.; Mantha, S.; Tjan, C.; Kaufmann, E. S.; Brenner, R.; Lowery, M. A.; Ku, G. Y.; Raj, N. P.; Shcherba, M.; Goldberg, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Krantz, B. A.; Tsui, D.; Lowery, M. A.; Capanu, M.; Yu, K. H.; Kelsen, D. P.; Gedvilaite, E.; Zhang, L.; Selcuklu, S. D.; You, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • NRG-GI002: A phase II clinical trial platform for sensitization testing using total neoadjuvant therapy (TNT) in rectal cancer
    Meeting Abstract

    George, T. J.; Yothers, G.; Hong, T. S.; Russell, M. M.; You, Y. N.; Parker, W.; Jacobs, S. A.; Pogue-Geile, K. L.; Gollub, M. J.; Hall, W. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Malignant diseases of the uterus
    Book Section

    Lakhman, Y.; Reinhold, C.
    In Hodler, J.; Kubik-Huch, R. A.; von Schulthess, G. K. (Eds.) Diseases of the Abdomen and Pelvis 2018-2021: Diagnostic Imaging - IDKD Book (2018)

    Fulltext@MSK | Save
  • Neuroendocrine gene transcripts: The role of molecular biomarkers in diagnosis and management
    Book Section

    Bodei, L.; Kidd, M.; Chung, K. M.; Modlin, I.
    In Giovanella, L. (Eds.) Atlas of Thyroid and Neuroendocrine Tumor Markers (2018)

    Fulltext@MSK | Save